Trial Outcomes & Findings for Natriuretic Brain Pro-peptid Changes in Patients With Chronic Heart Failure Within a Cardiac Rehabilitation Program (NCT NCT02087670)

NCT ID: NCT02087670

Last Updated: 2016-03-10

Results Overview

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

42 participants

Primary outcome timeframe

8 weeks

Results posted on

2016-03-10

Participant Flow

Outpatient with heart failure were recruited since March 2005 to January 2008.

Participant milestones

Participant milestones
Measure
Controlled, Supervised Exercise Protocol
controlled, supervised exercise protocol within a cardiac rehabilitation program controlled, supervised exercise protocol: exercise program within a cardiac rehabilitation program
Community Based Exercise
educational program and not supervises exercise program
Overall Study
STARTED
20
22
Overall Study
COMPLETED
17
20
Overall Study
NOT COMPLETED
3
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Controlled, Supervised Exercise Protocol
controlled, supervised exercise protocol within a cardiac rehabilitation program controlled, supervised exercise protocol: exercise program within a cardiac rehabilitation program
Community Based Exercise
educational program and not supervises exercise program
Overall Study
Withdrawal by Subject
3
2

Baseline Characteristics

Natriuretic Brain Pro-peptid Changes in Patients With Chronic Heart Failure Within a Cardiac Rehabilitation Program

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Controlled, Supervised Exercise Protocol
n=20 Participants
controlled, supervised exercise protocol within a cardiac rehabilitation program controlled, supervised exercise protocol: exercise program within a cardiac rehabilitation program
Community Based Exercise
n=22 Participants
educational program and not supervises exercise program
Total
n=42 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
20 Participants
n=5 Participants
22 Participants
n=7 Participants
42 Participants
n=5 Participants
Age, Categorical
>=65 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Continuous
57 years
STANDARD_DEVIATION 14 • n=5 Participants
55 years
STANDARD_DEVIATION 13 • n=7 Participants
55 years
STANDARD_DEVIATION 11 • n=5 Participants
Sex: Female, Male
Female
10 Participants
n=5 Participants
11 Participants
n=7 Participants
21 Participants
n=5 Participants
Sex: Female, Male
Male
10 Participants
n=5 Participants
11 Participants
n=7 Participants
21 Participants
n=5 Participants
Region of Enrollment
Colombia
20 participants
n=5 Participants
22 participants
n=7 Participants
42 participants
n=5 Participants
Natriuretic Brain pro-peptide
429 pg/ml
n=5 Participants
278 pg/ml
n=7 Participants
386 pg/ml
n=5 Participants
Oxygen Consumption
832 ml/min
STANDARD_DEVIATION 228 • n=5 Participants
811 ml/min
STANDARD_DEVIATION 229 • n=7 Participants
821 ml/min
STANDARD_DEVIATION 226 • n=5 Participants

PRIMARY outcome

Timeframe: 8 weeks

Outcome measures

Outcome measures
Measure
Controlled, Supervised Exercise Protocol
n=19 Participants
controlled, supervised exercise protocol within a cardiac rehabilitation program controlled, supervised exercise protocol: exercise program within a cardiac rehabilitation program
Community Based Exercise
n=22 Participants
educational program and not supervises exercise program
Natriuretic Brain Pro-peptid
312 pg/ml
Interval 24.0 to 2312.0
200 pg/ml
Interval 14.0 to 3481.0

SECONDARY outcome

Timeframe: 8 weeks

Outcome measures

Outcome measures
Measure
Controlled, Supervised Exercise Protocol
n=17 Participants
controlled, supervised exercise protocol within a cardiac rehabilitation program controlled, supervised exercise protocol: exercise program within a cardiac rehabilitation program
Community Based Exercise
n=20 Participants
educational program and not supervises exercise program
Oxygen Consumption
831 ml/min
Standard Deviation 250
919 ml/min
Standard Deviation 298

Adverse Events

Controlled, Supervised Exercise Protocol

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Community Based Exercise

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jesus Alberto Plata Contreras

Universidad de Antioquia

Phone: 5742196478

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place